1 study found for:    NCT00202839
Show Display Options
Rank Status Study
1 Completed
Has Results
Peg-Intron/Ribavirin in G 1 HCV for Non-Extended Versus 24 Week Extended Treatment After 24 Weeks (Study P04144)(COMPLETED)
Condition: Hepatitis C, Chronic
Interventions: Biological: PegIntron (peginterferon alfa-2b; SCH 54031);   Drug: Ribavirin

Indicates status has not been verified in more than two years